started · updated
Alzheimer’s research advances with predictive blood and genetic testing
Recent medical research is advancing the ability to predict Alzheimer’s disease years before symptoms appear. A Columbia University study published in The Lancet Neurology suggests that combining a blood test for the p-tau217 protein with an APOE genetic test can forecast the onset of clinical symptoms in high-risk, asymptomatic individuals by three to six years.
While these diagnostic tools show promise, medical experts urge caution regarding their use in healthy individuals. The U.S. Food and Drug Administration has cleared four blood tests specifically to help diagnose Alzheimer’s in patients already exhibiting cognitive symptoms. Experts, including Nicholas Ashton of Banner Health, advise that the “worried well” should not seek these tests outside of research settings, as the clinical implications for asymptomatic people are not yet fully understood.
Parallel research is also shifting the understanding of the disease's biological origins. New animal studies suggest that the harmful immune response in Alzheimer’s may actually begin in the lymph nodes rather than the brain itself. Additionally, researchers emphasize that lifestyle interventions—such as managing blood pressure, diabetes, and smoking—remain the most effective ways to reduce dementia risk, with some studies showing these habits can extend dementia-free life by nearly 13 years.
Entities
Alzheimer's disease · Banner Health · Columbia University · FDA · Josef Coresh · NYU Langone Health · Nicholas Ashton · U.S. Food and Drug Administration
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 4 SOURCES] The immune activation process involves dendritic cells. www.fehmarn24.de · www.kurierverlag.de · www.tz.de
- [● 4 SOURCES] Immune activity linked to Alzheimer-like brain damage may originate outside the brain. www.fehmarn24.de · www.kurierverlag.de · www.tz.de
- [● 4 SOURCES] T-cells receive instructions from lymph nodes rather than the brain itself. www.fehmarn24.de · www.kurierverlag.de · www.tz.de
- [● 4 SOURCES] The study utilized mice that develop Tau protein fibrils. www.fehmarn24.de · www.kurierverlag.de · www.tz.de
- [○ 1 SOURCE] CD8+-T-cells receive instructions in the deep cervical lymph nodes in the neck.
- [○ 1 SOURCE] CD8+-T-cells are responsible for the destruction of nerve tissue.
- [○ 1 SOURCE] A combination of p-tau217 blood tests and APOE genetic testing can predict Alzheimer's symptoms 3 to 6 years in advance. borncity.com
- [○ 1 SOURCE] The APOE ε4 variant increases Fibronectin levels in the blood-brain barrier, potentially causing leakage. borncity.com